RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00000048.xml
Osteosynthesis and Trauma Care 2005; 13(4): 254-260
DOI: 10.1055/s-2005-872479
DOI: 10.1055/s-2005-872479
Original Article
© Georg Thieme Verlag Stuttgart · New York
Bone Morphogenic Proteins: Their Role in Fracture Management
Weitere Informationen
Publikationsverlauf
Publikationsdatum:
01. Dezember 2005 (online)
Abstract
Delayed fracture healing and non-union remain problems in fracture management. Over the last two decades improvement with fixation has assisted with the management of these problems. Bone morphogenic proteins represent a novel approach to biologically stimulate fractures to accelerate bone healing. This article overviews some of the experimental and clinical studies to support the use of this technique.
Key words
Bone morphogenic protein - delayed bone healing - fracture management
References
- 1 Bassett C A, Mitchell S N, Gaston S R. Treatment of ununited tibial diaphyseal fractures with pulsing electromagnetic fields. J Bone Joint Surg [Am]. 1981; 63 511-523
- 2 Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg [Am] 2002 84: 2123-2134
- 3 Boden S D, Martin G J, Morone M A, Ugbo J L, Moskovitz P A. Posterolateral lumbar intertransverse process spine arthrodesis with recombinant human bone morphogenitic protein 2/hydroxyapatite-tricalcium phosphate after laminectomy in the nonhuman primate. Spine. 1999; 24 1179-1185
- 4 Boden S D, Zdeblick T A, Sandhu H S, Helm S E. The use of rhBMP-2 in inter-body fusion cages. Definitive evidence of osteoinduction in humans; a preliminary report. Spine. 2000; 25 376-381
- 5 Bogoch E R, Moran E L. Bone abnormalities in the surgical treatment of patients with rheumatoid arthritis. Clin Orthop. 1999; 8 21
- 6 Bonatus T, Olson S A, Lee S, Chapman M W. Nonreamed locking intramedullary nailing for open fractures of the tibia. Clin Orthop. 1997; 339 58-64
- 7 Boyd H B, Lipinski S W, Wiley J H. Observations on non-union of the shafts of the long bones, with a statistical analysis of 842 patients. J Bone Joint Surg [Am]. 1961; 43 159-168
- 8 Boyne P J, Marx R E, Nevins M, Triplett G, Lazaro E, Lilly L C, Alder M, Nummikoski P. A feasibility study evaluating rhBMP-2/absorbable collagen sponge for maxillary sinus floor augmentation. Int J Periodontics Restorative Dent. 1997; 17 11-25
- 9 Brighton C T, Shaman P, Heppenstall R B, Esterhai J L, Pollack S R, Friedenberg Z B. Tibial non-union treated with direct current, capacitive coupling or bone graft. Clin Orthop. 1995; 321 223-234
- 10 Carter D R, Blenman P R, Beaupre G S. Correlations between mechanical stress history and tissue differentiation in initial fracture healing. J Orthop Res. 1988; 6 736-748
- 11 Caudle R J, Stern P J. Severe open fractures of the tibia. J Bone Joint Surg [Am]. 1987; 69 801-807
- 12 Chen X, Kidder L S, Lew W D. Osteogenic protein-1 induced bone formation in an infected segmental defect in the rat femur. J Orthop Res. 2002; 20 142-150
- 13 Cook S D, Baffes G C, Wolfe M W, Sampath T K, Rueger D C. Recombinant human bone morphogenic proten-7 induces healing in a canine long bone segmental defect model. Clin Orthop. 1994; 30 302-312
- 14 Cook S D, Baffes G C, Wolfe M W, Sampath T K, Rueger D C, Whitecloud T S. Effect of recombinant human osteogenic protein-l on healing of large segmental bone defects. J Bone Joint Surg [Am]. 1994; 76 827-838
- 15 Cook S D, Salkeld S L, Brinker M R, Wolfe M W, Rueger D C. Use of an osteoinductive biomaterial (rhOP-1) in healing large segmental bone defects. J Orthop Trauma. 1998; 12 407-412
- 16 Cook S D, Wolfe M W, Salkeld S L, Rueger D C. Recombinant human osteogenic protein-1 (rhOP-1) heals segmental defects in nonhuman primates. J Bone Joint Surg [Am]. 1995; 77 734-750
-
17 Day S M, Ostrum R F, Chao E YS, Rubin C T, Aro H T, Einhorn T A. Bone injury, regeneration and repair. In: Buckwalter JA, Einhorn TA, Simon SR (eds). Orthopaedic basis science - biology and biomechanical of the musculoskeletal system. American Academy of Orthopaedic Surgeons, Rosemont, IL 2000; 371
- 18 Einhorn T A, Levine B, Michel P. Nutrition and bone. Orthop Clin North Am. 1990; 21 4350
- 19 Fischgrund J S, James S B, Chabot M C, Hankin R, Herkowitz H N, Wozney J M, Shirkhoda A. Augmentation of autograft using rhBMP-2 and different carrier media in the canine spinal fusion model. J Spinal Disord. 1997; 10 467-472
- 20 Friedlaender G E, Perry C R, Cole D, Cook S D, Ciemy G, Muschler G F, Zych G A, Calhoun J H, LaForte, Yin S. Osteogenic protein-1 (bone morphogenic protein-7) in the treatment of tibial non-unions. J Bone Joint Surg [Am]. 2001; 83 (suppl I, part 2) 151-158
- 21 Geesink R GT, Hoefnagels N HM, Bulstra S K. Osteogenic activity of OP-1 bone morphogenic protein (BMP-7) in a human fibular defect. J Bone Joint Surg [Br]. 1999; 81 710-718
- 22 Heppenstall R B, Brighton C T, Esterhai J R, Muller G. Prognosis factors in non-unions of the tibia; an evaluation of 185 cases treated with constant direct current. J Trauma. 1984; 24 790-795
- 23 Kwiatowski T C, Hanley E N, Ramp W K. Cigarette smoking and its orthopaedic consequences. Am J Orthop. 1996; 25 590-597
- 24 Kyro A, Usenius J P, Aamio M, Kunnamo I, Avikainen V. Are smokers a risk group for delayed healing of tibial shaft fractures?. Ann Chir Gynaecol. 1993; 82 254-262
- 25 Mayr E, Frankel V, Ruter A. Ultrasound - an alternative healing method for nonunions?. Arch Orthop Trauma Surg. 2000; 120 1-8
- 26 Patel T C, Erulkar J S, Grauer I N, Troiano N W, Panjabi M M, Friedlaender G E. Osteogenic protein-1 overcomes the inhibitory effect of nicotine on posterolateral lumbar fusion. Spine. 2001; 25 1656-1661
- 27 Perren S M. Physical and biological aspects of fracture healing with special reference to internal fixation. Clin Orthop. 1979; 138 175-196
-
28 Praemer A, Furner S, Rice D P. Musculoskeletal conditions in the United States. The American Academy of Orthopaedic Surgeons, Park Ridge, IL, 1992; 83
- 29 Riemer B L, DiChristina D G, Cooper A, Sagiv S, Butterfield S L, Burke C J, Lucke J F, Schlosser J D. Nonreamed nailing of tibial diaphyseal fractures in blunt polytrauma patients. J Orthop Trauma. 1995; 9 66-75
- 30 Ryaby J T. Clinical effects of electromagnetic and electric fields on fracture healing. Clin Orthop. 1998; 355 (Suppl) 205-215
- 31 Sampath T K, Ozkaynak E, Jones E, Sasa H, Tucker R, Tucker M. et al . Recombinant human osteogenic protein-1 (hOP-1) induces new bone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitro. J Biol Chem. 1992; 267 352-362
- 32 Sanders R, Jersinovich I, Anglen J, DiPasquale T, Herscovici D. The treatment of open tibial shaft fractures using an interlocked intramedullary nail without reaming. J Orthop Trauma. 1994; 8 501-510
- 33 Shimmin A, Ruff S. Clinical use of recombinant human osteogenic protein-1 (rhOP-1). Bone. 1999; 24 409-431
Dr. Russell MillerFRAC
Orthopaedic Clinic 2 · Alfred Hospital
Commercial Road
P.O. Box 315
Prahran, Victoria 3181
Australia
Fax: +61/3/92 76 22 22
eMail: rmiller3@bigpond.net.au